L H Augenlicht Selected Research

Colorectal Neoplasms (Colorectal Cancer)

11/2004	Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells.
11/2003	c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L H Augenlicht Research Topics

Disease

8	Colonic Neoplasms (Colon Cancer) 12/2008 - 08/2000
5	Neoplasms (Cancer) 12/2008 - 01/2001
3	Carcinoma (Carcinomatosis) 11/2003 - 12/2000
2	Carcinogenesis 12/2008 - 08/2001
2	Colorectal Neoplasms (Colorectal Cancer) 11/2004 - 11/2003
1	Breast Neoplasms (Breast Cancer) 10/2000

Drug/Important Bio-Agent (IBA)

3	beta CateninIBA 12/2008 - 10/2000
3	Volatile Fatty AcidsIBA 12/2008 - 08/2000
3	Butyrates (Butyrate)IBA 12/2008 - 08/2000
2	Sulindac (Copal)FDA LinkGeneric 08/2001 - 08/2000
2	Pharmaceutical PreparationsIBA 08/2001 - 08/2000
1	Transcription Factors (Transcription Factor)IBA 12/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2004
1	Platinum Compounds (Compounds, Platinum)IBA 11/2004
1	CamptothecinIBA 11/2003
1	Fluorouracil (Carac)FDA LinkGeneric 06/2001
1	CalciumIBA 01/2001
1	Phosphates (Orthophosphate)IBA 01/2001
1	MucinsIBA 01/2001
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2001
1	Vitamin D FDA LinkGeneric 01/2001
1	StaurosporineIBA 12/2000
1	Protein Kinases (Protein Kinase)IBA 12/2000
1	Cyclin D1IBA 10/2000
1	TCF Transcription FactorsIBA 10/2000
1	trichostatin A (A 300)IBA 08/2000
1	CurcuminIBA 08/2000

Therapy/Procedure

1	Therapeutics 06/2001
1	Chemoprevention 08/2000